Mar 4, 2023

Bowel cancer breakthrough as scientists find chemotherapy response could be predicted by existing NHS test

Posted by in categories: biotech/medical, innovation

Researchers hope KRAS test can serve renewed function as soon as possible Scientists have found an existing gene test frequently used on the NHS can also shed light on whether a bowel cancer patient will respond positively or negatively to chemotherapy. Researchers from The Institute of Cancer Research, Imperial College London and the Netherlands Cancer Institute have found the KRAS test can have use beyond its current function of predicting how patients will react to cancer drug cetuximab.

Leave a reply